NCT06885957View on ClinicalTrials.gov

Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
NMO Spectrum Disorder
Interventions
DRUG

Mab Therapy

Whether receive mab therapy or not.

Trial Locations (1)

430030

RECRUITING

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER

NCT06885957 - Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD | Biotech Hunter | Biotech Hunter